0

Percutaneous Coronary Intervention for Chronic Total Occlusion

The Hybrid Approach

Erschienen am 24.11.2022, 2. Auflage 2022
171,19 €
(inkl. MwSt.)

Lieferbar innerhalb 1 - 2 Wochen

In den Warenkorb
Bibliografische Daten
ISBN/EAN: 9783031054365
Sprache: Englisch
Umfang: xvii, 373 S., 82 s/w Illustr., 150 farbige Illustr
Einband: gebundenes Buch

Beschreibung

The second edition of this essential text provides readers with a detailed guide to performing various percutaneous coronary intervention (PCI) techniques for treating coronary chronic total occlusion (CTO). PCI continues to be an effective procedure to help patients with this pathology, with high success and low complications rates. Chapters feature a step-by-step approach to relevant techniques and describe their potential pitfalls, enabling the reader to develop a thorough understanding of how to perform those procedures successfully. Details of the latest methods for angiography analysis and the management of ostial CTOs, plus heavily revised chapters on topics such as contemporary device-based antegrade dissection and the retrograde approach through septal and non-septal collateral channels ensure that this Work remains the most up-to-date reference on the subject. Percutaneous Intervention for Coronary Chronic Total Occlusion: The Hybrid Approach represents a vital reference to assist practicing and trainee interventional cardiologist in learning these techniques. Various examples are provided, with a vast selection of still images and angiographic video loops to enable the reader become confident in applying these methodologies into their day-to day clinical practice.

Produktsicherheitsverordnung

Hersteller:
Springer Verlag GmbH
juergen.hartmann@springer.com
Tiergartenstr. 17
DE 69121 Heidelberg

Autorenportrait

Dr Stéphane Rinfret is an academic interventional cardiologist and world-renowned expert in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). He completed a general and interventional cardiology fellowship at University of Montreal in 1999. He pursued a postgraduate fellowship at the Beth Israel Deaconess Medical Center and Harvard Clinical Research Institute (Harvard University), which he completed in 2001. He also obtained a Science Master's (S.M.) degree in clinical epidemiology at the Harvard School of Public Health in 2001. Dr Rinfret spent the first 7 years of his career at the University of Montreal and moved in 2008 to the Laval University-Quebec Heart and Lung Institute where he spent 7 years and performed the first retrograde CTO PCI in Canada. He moved back to Montreal in 2016 to become the Director of Interventional Cardiology at the McGill University Health Centre where he built a high-volume CTO and Complex Higher risk but Indicated Procedures (CHIP) program. He moved to the United States in 2021 after being recruited at Emory Heart and Vascular and was appointed professor of Medicine at Emory University. He has published over 160 peer-reviewed articles and has been invited over 300 times to give lectures in the past 10 years. He is a high-volume coronary operator, with procedures performed predominantly in high-risk patients turned down for Coronary Artery Bypass Grafting (CABG) or with a complex post CABG coronary anatomy. He is the founder and co-director of the Multi-Level CTO course, the largest CTO-dedicated course in Europe. Dr Rinfret serves as faculty in many important cardiology meetings, and pursues very active clinical, research, proctoring and teaching career.

Weitere Artikel vom Autor "Stéphane Rinfret"

Alle Artikel anzeigen